Shexiang Baoxin Pill, a Proprietary Multi-Constituent Chinese Medicine, Prevents Locomotor and Cognitive Impairment Caused by Brain Ischemia and Reperfusion Injury in Rats: A Potential Therapy for Neuropsychiatric Sequelae of Stroke

Ischemic stroke is a common type of cerebrovascular event and also the leading cause of disability. Post-stroke cognitive impairment occurs frequently in stroke survivors. Shexiang Baoxin Pill (SBP) is a proprietary Chinese medicine, initially used to treat cardiovascular diseases. Herein, we aim to...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Zong-Shi, Zheng, Yu, Zhou, Xi-Dan, Shi, Dong-Dong, Cheng, Dan, Shek, Chun Shum, Zhan, Chang-Sen, Zhang, Zhang-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111446/
https://www.ncbi.nlm.nih.gov/pubmed/33986688
http://dx.doi.org/10.3389/fphar.2021.665456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111446/
https://www.ncbi.nlm.nih.gov/pubmed/33986688
http://dx.doi.org/10.3389/fphar.2021.665456

Ejemplares similares